RecruitingNot ApplicableNCT06852950

Continuous Glucose Monitoring for Outpatient Diabetes Management After Hospital Discharge


Sponsor

Vanderbilt University Medical Center

Enrollment

60 participants

Start Date

Mar 9, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This study aims to improve patient awareness of the utility of continuous glucose monitoring systems in blood glucose monitoring and to improve patient satisfaction regarding diabetes care, particularly in the matter of blood glucose monitoring, at the transitions of care from the inpatient setting to the ambulatory setting.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study tests whether using a continuous glucose monitor (a small wearable sensor that tracks blood sugar throughout the day) helps people with diabetes manage their blood sugar better after leaving the hospital. **You may be eligible if:** - You are 18 years or older - You were hospitalized and needed insulin to manage your blood sugar - Your blood sugar levels were between 70–350 mg/dL in the 24 hours before joining the study - You have a smartphone compatible with the FreeStyle Libre 3 or Dexcom G7 app - You can use the device on your own **You may NOT be eligible if:** - You have used a Libre 3 or Dexcom G7 sensor in the past 3 months - You received chemotherapy during your hospital stay - You are planning major surgery within 10–15 days - You are on dialysis - You are in intensive care or on a ventilator - You take high doses of vitamin C, hydroxyurea, or more than 4 grams of acetaminophen daily - You have severe swelling (edema) from liver, heart, or kidney problems - You are in diabetic ketoacidosis - You have a skin allergy to adhesives Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICELibre 3 Plus Continuous Glucose Monitor

Subjects in this arm will start using the Libre 3 Plus continuous glucose monitor.

DEVICEDexcom G7 Continuous Glucose Monitor

Subjects in this arm will start using the Dexcom G7 continuous glucose monitor.


Locations(1)

Vanderbilt University Medical Center

Nashville, Tennessee, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06852950


Related Trials